Header Ads Widget

Responsive Advertisement

TRENDING

6/recent/ticker-posts

DCGI approves Biological E`s phase 2 and 3 trials of COVID vaccine on children

India's drug regulator granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials on children for its anti-COVID drug called Corbevax. 

from Zee News :India National https://ift.tt/3kMHHxF

Post a Comment

0 Comments